Incretin-based GLP-1 receptor agonists and metabolic-modulator research compounds. All compounds in this category are licensed prescription-only medicines in the UK — they appear here for information and calculator purposes only. Stackcalc.co.uk does not sell these compounds.
Compounds in this category
Retatrutide
GLP-1/GIP/glucagon triple-receptor agonist. Investigational research compound, no UK marketing authorisation.
Semaglutide
GLP-1 receptor agonist. Licensed UK prescription medicine (Ozempic, Wegovy, Rybelsus).
Tirzepatide
GLP-1/GIP dual agonist. Licensed UK prescription medicine (Mounjaro).
Cagrilintide
Long-acting amylin analogue. Research-stage weight-loss compound.
5-amino-1-MQ
NNMT inhibitor. Emerging metabolic research compound.
Open the calculator
The universal calculator handles every compound in this category. Pick your specific compound from the dropdown, choose pen or vial mode, enter your strength and target dose — the calculator returns the exact maths for your research.
Compliance: Stackcalc.co.uk provides calculator tools and information for research and educational purposes only. We do not sell, supply, or recommend peptides, nootropics, or any other compounds. Content on this site does not constitute medical advice. Not for human consumption.